WHO has asked manufacturers of mpox in vitro diagnostics (IVDs) to submit an expression of interest for Emergency Use Listing (EUL). World health organization (WHO) has been in ongoing discussions with manufacturers about the need for effective diagnostics, particularly in low-income settings. The request for EUL expressions of interest by manufacturers is the latest development in these discussions.
Testing is key for people to get treatment and care as early as possible and prevent further spread. Since 2022, WHO has delivered around 150 000 diagnostic tests for Monkey Pox globally, of which over a quarter have gone to countries in the African Region. In the coming weeks, WHO will deliver another 30 000 tests to African countries – Read more.
A safe, reliable, affordable and easily accessible water supply is essential for good health. Globally, people of many nations—or high income regions within nations—now e...
Air pollution is a major problem affecting everyone in developed and developing countries alike, which has a serious toxicological impact on human health and the environm...
The World Health Organization (WHO) and UN partners have released the first progress report for the UN Decade of Healthy Ageing. The report highlights efforts to improve...
Overwhelming evidence is however showing that the current warming trend is particularly concerning as most of it extremely likely to be the result of human activity since...
A virtual marketplace leading your business into the future
